The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

GBA Parkinson’s disease alpha-synuclein cathepsin B iPSC lysosome

Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
15 Nov 2023
Historique:
pubmed: 28 11 2023
medline: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Variants in the

Identifiants

pubmed: 38014143
doi: 10.1101/2023.11.11.566693
pmc: PMC10680785
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NINDS NIH HHS
ID : K02 NS080915
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000040
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AG000935
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA NS003154
Pays : United States

Références

PLoS One. 2013;8(1):e55375
pubmed: 23383169
Brain. 2019 Jan 1;143(1):234-248
pubmed: 31755958
Chem Biol. 2000 Jan;7(1):27-38
pubmed: 10662686
Elife. 2016 Sep 23;5:
pubmed: 27661255
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
J Neurosci. 2004 Feb 25;24(8):1888-96
pubmed: 14985429
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Rev Neurosci. 2021 Feb;22(2):111-131
pubmed: 33432241
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Cell Rep. 2022 Jul 19;40(3):111102
pubmed: 35858558
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982
pubmed: 32075919
Bioinformatics. 2016 May 15;32(10):1493-501
pubmed: 26773131
Mol Neurodegener. 2023 May 2;18(1):29
pubmed: 37131250
Neurobiol Dis. 2015 Jan;73:244-53
pubmed: 25466281
J Mol Biol. 2023 Jun 15;435(12):168023
pubmed: 36828270
J Neurochem. 2017 Feb;140(4):662-678
pubmed: 27424880
J Exp Med. 2016 Sep 19;213(10):2081-97
pubmed: 27551156
Cell Death Dis. 2023 Apr 8;14(4):255
pubmed: 37031185
Am J Hum Genet. 2013 Jul 11;93(1):42-53
pubmed: 23768515
Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71
pubmed: 15451225
Ann Neurol. 2018 Jul;84(1):117-129
pubmed: 30146727
Ageing Res Rev. 2016 Dec;32:22-37
pubmed: 27125852
Transl Neurodegener. 2023 Jun 13;12(1):31
pubmed: 37312133
Biochemistry. 2022 Feb 15;61(4):228-238
pubmed: 35119840
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Brain Commun. 2021 Sep 25;3(4):fcab223
pubmed: 34632384
Methods. 2022 Jul;203:465-477
pubmed: 34314827
Cell. 2022 Jun 23;185(13):2292-2308.e20
pubmed: 35750034
Lancet Neurol. 2019 Dec;18(12):1091-1102
pubmed: 31701892
Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2303789120
pubmed: 37487100
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
Anal Chem. 2014 Jul 15;86(14):7150-8
pubmed: 24927332
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931-6
pubmed: 26839413
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9322-7
pubmed: 26170293
Eur J Neurosci. 2019 Feb;49(4):510-524
pubmed: 30472757
Autophagy. 2016 Dec;12(12):2504-2505
pubmed: 27786577
Nat Methods. 2020 Nov;17(11):1093-1096
pubmed: 33020655
J Biol Chem. 2019 Jun 21;294(25):9973-9984
pubmed: 31092553
Biostatistics. 2012 Sep;13(4):762-75
pubmed: 22699862
Nucleic Acids Res. 2023 Jan 6;51(D1):D638-D646
pubmed: 36370105
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
J Biol Chem. 2017 Aug 11;292(32):13482-13497
pubmed: 28611062
Methods Protoc. 2021 Jul 19;4(3):
pubmed: 34287353
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Front Neurosci. 2020 May 15;14:442
pubmed: 32499675
Mov Disord. 2021 Aug;36(8):1795-1804
pubmed: 33960523
Bone. 2018 Aug;113:41-48
pubmed: 29763751
Mol Pharmacol. 2021 Dec;100(6):526-539
pubmed: 34503973
Hum Mol Genet. 2015 Nov 1;24(21):6013-28
pubmed: 26251043
Parkinsonism Relat Disord. 2020 Apr;73:60-71
pubmed: 31761667
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2389-2394
pubmed: 28193887
J Immunol. 2015 Aug 15;195(4):1685-97
pubmed: 26195813
eNeuro. 2019 Mar 7;6(1):
pubmed: 30863790
J Biol Chem. 2010 Apr 30;285(18):13621-9
pubmed: 20200163
J Biol Chem. 2020 Dec 18;295(51):17497-17513
pubmed: 33453994
J Biol Chem. 2008 Aug 29;283(35):23542-56
pubmed: 18566453
BMC Bioinformatics. 2014 May 02;15:125
pubmed: 24884706
Brain. 2023 Oct 06;:
pubmed: 37804111
Stem Cells Transl Med. 2020 Jun;9(6):697-712
pubmed: 32154672
Neurobiol Aging. 2020 Sep;93:143.e1-143.e4
pubmed: 32371106
Nat Methods. 2022 Jul;19(7):829-832
pubmed: 35654950
Brain. 2021 Mar 3;144(2):462-472
pubmed: 33349842
Hum Mol Genet. 2022 Jul 21;31(14):2424-2437
pubmed: 35181782

Auteurs

Jace Jones-Tabah (J)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Kathy He (K)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Konstantin Senkevich (K)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Nathan Karpilovsky (N)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Ghislaine Deyab (G)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Yuting Cousineau (Y)

Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Daria Nikanorova (D)

Research Department, Bioinformatics Institute, Saint-Petersburg, Russia.

Taylor Goldsmith (T)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Esther Del Cid Pellitero (E)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Carol X-Q Chen (CX)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Wen Luo (W)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Zhipeng You (Z)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Narges Abdian (N)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Isabella Pietrantonio (I)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Thomas Goiran (T)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Jamil Ahmad (J)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Jennifer A Ruskey (JA)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Farnaz Asayesh (F)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Human Genetics, McGill University, Montréal, Canada.

Dan Spiegelman (D)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.

Cheryl Waters (C)

Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, NY, USA.

Oury Monchi (O)

Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
Département de radiologie, radio-oncologie et médecine nucléaire, Université de Montréal, Montréal, QC, Canada.
Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.

Yves Dauvilliers (Y)

National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.

Nicolas Dupré (N)

Neuroscience Axis, CHU de Québec - Université Laval, Quebec City, G1V 4G2, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, G1V 0A6, Canada.

Irina Miliukhina (I)

Institute of the Human Brain of RAS, St. Petersburg, Russia.

Alla Timofeeva (A)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Anton Emelyanov (A)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Sofya Pchelina (S)

First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.

Lior Greenbaum (L)

Institute of the Human Brain of RAS, St. Petersburg, Russia.
First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Sharon Hassin-Baer (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
The Movement Disorders Institute, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.

Roy N Alcalay (RN)

Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, NY, USA.
Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Austen Milnerwood (A)

Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Thomas M Durcan (TM)

Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.

Ziv Gan-Or (Z)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Human Genetics, McGill University, Montréal, Canada.

Edward A Fon (EA)

McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Classifications MeSH